Enzymes for Research, Diagnostic and Industrial Use
Our Products Cannot Be Used As Medicines Directly For Personal Use.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
Restriction enzymes were first discovered in the early 1970s in studies of bacterial defense mechanisms, where they serve to protect bacteria from foreign DNA, such as that from viruses (bacteriophages). These enzymes recognize short, specific sequences of DNA, typically ranging from 4 to 8 base pairs, and cleave the double-stranded DNA at or near these sites. The cleaved fragments, known as restriction fragments, can then be analyzed, manipulated, or recombined. There are three main types of restriction enzymes: Type I, Type II, and Type III, each with distinctive recognition and cleavage properties. Type II restriction enzymes, which include SrfI, are of particular interest in molecular cloning and genetic engineering due to their predictability and reliability. They recognize palindromic sequences and cut the DNA at specific sites, allowing scientists to splice genes into plasmids, create recombinant DNA, and conduct various genetic manipulations.
SrfI was first isolated from Streptomyces griseus, a species of bacteria known for its ability to produce a variety of secondary metabolites, including antibiotics. The isolation of enzymes from such organisms has been a fruitful area of research, as these enzymes often possess unique characteristics that make them advantageous for various biotechnological applications.
SrfI is characterized as a Type II restriction enzyme, which typically consists of a single polypeptide chain that aids in the recognition and cleavage of DNA. One of the defining features of SrfI is its ability to recognize a specific palindromic sequence, which is important for its function in DNA manipulation. The crystal structures of SrfI reveal distinct domains that are responsible for DNA binding and catalysis. The enzyme has an N-terminal domain that serves to bind the DNA and a C-terminal domain that harbors the catalytic activity. This spatial organization allows SrfI to interact with its target sequence efficiently, making it a highly effective cutting agent.
SrfI was first isolated from Streptomyces griseus, a species of bacteria known for its ability to produce a variety of secondary metabolites, including antibiotics. The isolation of enzymes from such organisms has been a fruitful area of research, as these enzymes often possess unique characteristics that make them advantageous for various biotechnological applications.
SrfI is characterized as a Type II restriction enzyme, which typically consists of a single polypeptide chain that aids in the recognition and cleavage of DNA. One of the defining features of SrfI is its ability to recognize a specific palindromic sequence, which is important for its function in DNA manipulation.
The crystal structures of SrfI reveal distinct domains that are responsible for DNA binding and catalysis. The enzyme has an N-terminal domain that serves to bind the DNA and a C-terminal domain that harbors the catalytic activity. This spatial organization allows SrfI to interact with its target sequence efficiently, making it a highly effective cutting agent.
SrfI recognizes the palindromic DNA sequence 5'-GCGC-3' and cleaves the DNA strand between the nucleotides. The recognition and cleavage process involves several steps:
The unique characteristics of SrfI and its ability to cleave DNA at specific sites make it a valuable tool in molecular biology.
One of the primary applications of SrfI lies in genetic engineering, where it is employed for cloning, gene editing, and constructing recombinant DNA molecules. The ability to cut DNA at precise locations allows scientists to insert, delete, or modify genes within a genome, paving the way for advancements in plant and animal sciences, as well as in human health.
In molecular cloning, SrfI can be used to create recombinant DNA by inserting a gene of interest into a plasmid vector. By cleaving the vector and the gene with SrfI, the compatible ends can be ligated together, allowing for the propagation of the desired gene within host organisms. This technique has extensive